We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK has authorized the use of the corticosteroid dexamethasone to reduce the risk of death in COVID-19 patients requiring ventilation or oxygen. Read More